• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Translational Research - New Innovation Model
 

Translational Research - New Innovation Model

on

  • 1,780 views

A model for translating and validating discoveries within a University Environment.

A model for translating and validating discoveries within a University Environment.

Statistics

Views

Total Views
1,780
Views on SlideShare
1,748
Embed Views
32

Actions

Likes
0
Downloads
26
Comments
0

3 Embeds 32

http://www.linkedin.com 15
https://www.linkedin.com 15
http://sitekreator.com 2

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Translational Research - New Innovation Model Translational Research - New Innovation Model Presentation Transcript

    • New Innovation ModelDiscovery through Validation
    • Innovator’s DNA 5 Skills that result in Innovation Experiment Network Question Observe AssociateDyer, H., Gregersen, H. & Christensen, C. (2009) TheInnovator’s DNA,. Harvard Business Review, 87 (12):60-7, 128.
    • Question: Is the “Business Model” of the research University meeting theneeds of its stakeholders in today’s environment?
    • Observation:Federal Funding Flattening or Decreasing
    • Observation:Tuition Growth NOT Sustainable
    • Observation: The University EnvironmentFocused on academic excellenceResearch labs focused on basic researchand discoverySystems in place to reward publishingIntellectual property policies consistentwith Bayh-Dole Act
    • Observation: Economic Development Mission Purdue University: Promoting discovery with delivery by conducting field-defining research with breakthrough outcomes and catalyzing research-based economic development and entrepreneurship. Indiana University: Indiana University is a partner in helping to transform the Hoosier economy, and a key result of the [Strategic Plan] will be new innovations and transferableresearch that together will help create the basis for economic transformation and growth in Indiana. The Ohio State University: Become a catalyst for the development of Ohio’s technology-based economy. Increase collaborations with the private sector to enhance research, successfully transfer University technology, and provide experiential learning opportunities for students.
    • Observation: Emerging Industry Support Purdue GIT MIT U of M CMUIndustry Expend/Total 13% 8% 7% 4% 8%License/FTE 8.5 7.2 2.8 2.7 3.1Startups 10 9 18 10 8Startups/Licenses 12% 14% 20% 53% 10%
    • Observation: The U.S. Corporate EnvironmentPressure to focus limited resources oncore strengthsDesire and pressure to outsource asmuch as possible, including research,discovery, and development activitiesDesire to keep R & D in U.S.
    • Observation: Outsourcing of “Discovery” Growing Drug Discovery Outsourcing Market ($B)$16.0 $13.8$14.0 $11.8$12.0 $10.0$10.0 $8.4 $7.3 $8.0 $6.3 $5.4 $6.0 $4.7 $4.1 $4.0 $2.0 $0.0 2005 2006 2007 2008 2009 2010 2011 2012 2013
    • Observation:Academic - Focus on Basic Research Product Dev. Translational Research Basic Research
    • Observation:Industry - Focus on Product Development Product Development Translational Research Basic Research
    • ObservationAssociation:Emerging Model – Focus on Translational Research Product Dev. “Valley of Death” Translational Research Basic Research
    • Association: Need for PublicPrivate Strategic Partnerships with focus on Translational Research•University’s need to explore and expandresearch funding sources•Industry needs to add more “R” to its “D”•Translational Research is common focus
    • Experiment: Manage multi-disciplinary team to defined “deliverable”Major Challenges to resolve:• Contracting and IP transfer verycomplicated• Individual Faculty utilize $$ for ownindividual objectives• Focus on publication not translation• No project management or coordination• Unfamiliarity with industry expectations• Academic culture and industry cultureare very different
    • Experiment: A test model for collaboration Kylin Therapeutics• Purdue Invention: pRNA – Self-assembling RNAnanoparticle• Goal: Develop therapeutic pRNA nanoparticlefor ovarian cancer• Deliverable: Proof of principle data package andclinical candidate• Partnership: Kylin sponsors research effort inthe Bindley Bioscience center & Kylin scientistsand Purdue scientists work cooperatively tocommon goal.
    • Experiment: A test model for collaboration Kylin Therapeutics Concept Concept Publish FundingPublish Funding Discovery Discovery Delivery Current Basic Research Model New Innovation Research Model
    • Experiment: A test model for collaboration Kylin Therapeutics Experimental Observations since 2007 University Mission• Average of 6 full-time staff (avg. $69k per year)• $574K in sponsored research since 2007• 3 publications• 2 manuscripts in production• Diverse research opportunities• 1 post-doc• 2 research internships• 1 business internship• Opportunity to Network with Industry experts
    • Experiment: A test model for collaboration Kylin Therapeutics Experimental Observations since 2007 Industry Mission• 3 patent applications• 3 publications• 2 Manuscripts in production• Pharmacological characterization of pRNAcompleted• Novel pRNA chemical synthesis methodsdeveloped• Opportunity to Network with Academic experts• $145K* per FTE* Average - Includes general lab and reagent supplies
    • Experiment: A test model for collaboration • Focus on “Delivery”Academic Industry Discovery • “Agile” projectExpertise management Joint Research Team • Multi-disciplinary Academic/Industry research teams Delivery • Culture of Entrepreneurship •Diverse Networking
    • Experiment: A test model for collaboration •Tech Transfer, Sponsored Research, Tech Transfer Research Team and Business Offices needBusiness to be aligned to a Office common mission Sponsored Program Services • Common metrics • “Service” oriented • Business Friendly
    • New Innovation ModelDiscovery through Validation Large Pharma and Biotech Animal Clinical Testing Trials Facility Translational Management – a virtual CRO GMP Mfg. Research Facility Staff Multi- disciplinary Academic Team
    • New Innovation ModelDiscovery through Validation Large Pharma Academic TeamUniv. Virtual CRO • ProblemIP • ExpertiseIP • Project • $ • Facilities Management • Expertise • Multi-disciplinary • Manage to approach “Deliverable” • Contract Support Negotiation GMP Mfg. Research Staff Animal Testing Clinical Trials• Outsourced • The “Hands” • Vivarium • Affiliated Mfg (if • Animal Hospitals required) Testing and • Clinical Trial Analysis Management
    • New Innovation ModelDiscovery through Validation Large Pharma and Biotech Animal Clinical Testing Trials Facility Translational Management GMP Mfg. Research Facility Staff Multi- disciplinary Academic Team Clinical Pipeline
    • New Innovation Model Recent Examples• Pfizer/UCSF: $85Million to fund biotherapeuticdiscovery and development•Johnson & Johnson/Vanderbilt: up to $100 Millionfor Schizophrenia drug development• AstraZeneca/Univ. College of London: Major stemcell collaboration•GenentechUCSF: $13 Million to fund discovery anddevelopment of neurodegenerative diseases
    • Discovery through Validation J. Eric Davis edavis@in-vivoventures.com 650-260-8923Value Proposition• Identify and assemble world-class research teamsIP• Negotiate and manage complex contracting process• Manage IP protection and transfer - Licensing• Manage research and development projects to Deliverable • Proof of principle data package • Problem resolution • Clinical Candidate• Average fully-loaded FTE cost $155K•Provide contract research staff Focus Areas Cancer HIV Infectious Disease Inflammation DiabetesObesity Neurological Disorders